WO2003077829A3 - Process for preparation of a pharmaceutical composition containing acid labile compounds - Google Patents

Process for preparation of a pharmaceutical composition containing acid labile compounds Download PDF

Info

Publication number
WO2003077829A3
WO2003077829A3 PCT/IB2003/000827 IB0300827W WO03077829A3 WO 2003077829 A3 WO2003077829 A3 WO 2003077829A3 IB 0300827 W IB0300827 W IB 0300827W WO 03077829 A3 WO03077829 A3 WO 03077829A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical composition
composition containing
acid labile
containing acid
Prior art date
Application number
PCT/IB2003/000827
Other languages
French (fr)
Other versions
WO2003077829A2 (en
Inventor
Bakulesh Mafatlal Khamar
Original Assignee
Bakulesh Mafatlal Khamar
Modi Rajiv Indravadan
Dave Brijesh
Ramani Chandir Chimandas
Naik Praful
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar, Modi Rajiv Indravadan, Dave Brijesh, Ramani Chandir Chimandas, Naik Praful filed Critical Bakulesh Mafatlal Khamar
Priority to AU2003208505A priority Critical patent/AU2003208505A1/en
Publication of WO2003077829A2 publication Critical patent/WO2003077829A2/en
Publication of WO2003077829A3 publication Critical patent/WO2003077829A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Abstract

Process for preparation of a pharmaceutical formulation containing an acid unstable compound together with an alkaline reacting substance as core material , one or more subcoating layer(s) and an enteric coating .
PCT/IB2003/000827 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds WO2003077829A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003208505A AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN235/MUM/2002 2002-03-08
IN235MU2002 2002-03-08

Publications (2)

Publication Number Publication Date
WO2003077829A2 WO2003077829A2 (en) 2003-09-25
WO2003077829A3 true WO2003077829A3 (en) 2003-12-04

Family

ID=27799867

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2003/000802 WO2003075825A2 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis
PCT/IB2003/000827 WO2003077829A2 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/000802 WO2003075825A2 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis

Country Status (4)

Country Link
KR (1) KR20050008452A (en)
AU (2) AU2003209534A1 (en)
GB (1) GB2392839A (en)
WO (2) WO2003075825A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
PL1948782T3 (en) 2005-04-25 2013-01-31 Cadila Pharmaceuticals Ltd Vaccine adjuvants
ATE524972T1 (en) * 2006-11-23 2011-10-15 Cadila Pharmaceuticals Ltd POLY-TLR ANTAGONIST
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247983A2 (en) * 1986-04-30 1987-12-02 Aktiebolaget Hässle New pharmaceutical preparation for oral use
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
WO1995001783A1 (en) * 1993-07-09 1995-01-19 Astra Aktiebolag New pharmaceutical formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
WO2003063897A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247983A2 (en) * 1986-04-30 1987-12-02 Aktiebolaget Hässle New pharmaceutical preparation for oral use
EP0496437A2 (en) * 1986-04-30 1992-07-29 Aktiebolaget Hässle Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole
EP0567201A2 (en) * 1986-04-30 1993-10-27 Aktiebolaget Hässle Vehicles for oral administration of a specific pharmaceutically active acid labile substance
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
WO1995001783A1 (en) * 1993-07-09 1995-01-19 Astra Aktiebolag New pharmaceutical formulation

Also Published As

Publication number Publication date
GB2392839A (en) 2004-03-17
WO2003075825A3 (en) 2003-11-13
GB2392839A8 (en) 2004-11-18
AU2003208505A1 (en) 2003-09-29
KR20050008452A (en) 2005-01-21
AU2003209534A8 (en) 2003-09-22
WO2003077829A2 (en) 2003-09-25
GB0400094D0 (en) 2004-02-04
WO2003075825A2 (en) 2003-09-18
AU2003208505A8 (en) 2003-09-29
AU2003209534A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
WO2005092297A3 (en) A stable pharmaceutical composition comprising an acid labile drug
HK1039070A1 (en) Pharmaceutical formulation comprising omeprazole
WO2006044202A3 (en) Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
YU60899A (en) Pharmaceutical formulation of omeprazole
HK1050357B (en) New -amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
WO2002081453A8 (en) Thiohydantoins and use thereof for treating diabetes
WO2005044240A3 (en) Stable lansoprazole formulation
AU2003268314A1 (en) Process for the preparation of a dry pesticidal composition containing a dicarbodylate component
AU5423200A (en) Stable benzimidazole formulation
SI1355635T1 (en) New film coating
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
WO2003077829A3 (en) Process for preparation of a pharmaceutical composition containing acid labile compounds
AU2003231920A1 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2004066982A8 (en) Stable oral benzimidazole compositions and processes for their preparation
WO2004075828A3 (en) Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
AU2001258200A1 (en) Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
CA2393483A1 (en) Stable pharmaceutical preparations comprising a benzimidazole and process for their production
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2002300093A1 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
WO2002038133A3 (en) Compositions containing hydrolytically unstable compounds
WO2006017787A3 (en) Tablet coating composition
AU2002215044A1 (en) 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-p iperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
AU2002311053A1 (en) Oxaliplatin active substance with a very low content of oxalic acid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP